"Their feelings would be unimaginable," she said.

The Federal Government announced on August 21 it would list Herceptin on the Pharmaceutical Benefits Scheme from October 1.

Herceptin is used to treat women with HER-2-positive early breast cancer, and costs $70,000 for a year's treatment.

The subsidy will cost the government about $470 million over the next four years and is expected to help about 2000 women each year.

Mrs Weiss, from Hepburn Springs, has undergone chemotherapy for breast cancer and started taking Herceptin in May after raising about $40,000 through an art and auction raffle.

"I have enough money to take me through the year but it's not about me, it's about others," she said.

After a lot of false hope, Mrs Weiss hoped Herceptin would be on the PBS in October.

"Hopefully it will come to an end in October. It won't be until they say we are having it free that I will be really happy," she said.

"We will just wait and see but it is good news for other patients who can't afford it."

Mrs Weiss said Herceptin, which is claimed to reduce the chances of the cancer returning by almost half, does not treat all women.

She said there was a new drug yet to be approved, called Tykerb, used as a backup for Herceptin.

"All I can hope is that it (Herceptin) will work for me," she said.

"The community went through a lot of time helping me buy the drug."

Mrs Weiss said her family and the community had been really good throughout her ordeal.

"There are so many people who have helped me," she said.

"You want to cry when people are nice to you but you can't cry all of the time."

She said she was feeling relatively well after five rounds of treatment.

She will finish the treatment in May.